Ventilator-free DaysPReVENT-NLNCT02153294
PRotective VENTilation in Patients Without ARDS
A study testing low tidal volume and high tidal volume in people with Ventilator-free Days, run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) at 1 site in Netherlands.
Trial summary
The purpose of this national multicentre randomized controlled trial is to compare a ventilation strategy using lower tidal volumes and higher respiratory rates with a ventilation strategy using higher tidal volumes and a lower respiratory rate in intubated and ventilated intensive care unit (ICU) patients without… Read more about this study
- Who is it for?
- Ages 18 to 100 years
- Conditions the study is for
- Ventilator-free Days
- What is being tested?
- low tidal volume and high tidal volume
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 952 participants
- Where
- 1 siteNetherlands
- Study dates
- Aug 2014to 18 Nov 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Admission to an ICU participating in this trial
- Need for intubation
- Within 1 hour of admission from the operation room or emergency room (if still intubated and ventilated), or within 1 hour of start of invasive ventilation in the ICU
- An expected duration of ventilation > 24 hours
Who cannot join
- Age less than 18 years
- Patients previously randomized in PReVENT
- Patients participating in other interventional trials
- Patients with a clinical diagnosis of ARDS according to the Berlin definition
- Patients with a PaO2/FiO2 < 200 mm Hg in whom hypoxia is presumably not caused by cardiac failure or fluid overload
- Invasive ventilation longer than 12 hours directly preceding admission
Show all 13Show fewer
- Patients with suspected or confirmed pregnancy
- Patients with increased and uncontrollable intracranial pressure (of ≥18 mmHg)
- Patients with GOLD classification III or IV chronic obstructive pulmonary disease (COPD)
- Patients with asthmatic status
- Patients with premorbid restrictive pulmonary disease (evidence of chronic interstitial infiltration on previous chest radiographs)
- Patients with new proven pulmonary thrombo-embolism
- Patients with any previous pneumectomy or lobectomy
Trial locations and contacts
1 site in 1 country.
Netherlands1 site
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Amsterdam
About this study
Official title: PRotective VENTilation in Patients Without ARDS at Start of Ventilation - PReVENT, a Randomized Controlled Trial
The purpose of this national multicentre randomized controlled trial is to compare a ventilation strategy using lower tidal volumes and higher respiratory rates with a ventilation strategy using higher tidal volumes and a lower respiratory rate in intubated and ventilated intensive care unit (ICU) patients without Acute Respiratory Distress Syndrome (ARDS) at start of ventilation.
Participating centres in The Netherlands will include a total of 952 adult patients admitted to intensive care units without ARDS. Patients are randomized and ventilated with either a strategy with lower tidal volumes (4 to 6 ml/kg predicted body weight (PBW)) or a strategy with higher tidal volumes (8 to 10 ml/kg PBW). Patients will be assessed every day until day 28 or discharge of the intensive care unit, whichever comes first, on day 28 and on day 90. Primary endpoint is the number of ventilator-free days at day 28. Secondary endpoints are ICU- and hospital length of stay (LOS) and - mortality, the incidence of development of ARDS, pneumonia, atelectasis, and pneumothorax, the cumulative use and duration of sedatives, and neuromuscular blocking agents, incidences of ICU delirium and ICU acquired weakness, patient-ventilator asynchrony and the need for decreasing of instrumental dead space.
Read the detailed description
Research question:
Does mechanical ventilation with lower tidal volumes, as compared with mechanical ventilation with higher tidal volumes, increase the number of ventilator-free days at day 28 in patients without ARDS at start of ventilation?
Study Design:
An investigator-initiated, national, multicenter, parallel randomized controlled two-arm trial.
Centers:
Five centers in The Netherlands will participate in this trial;
- Academic Medical Center, University of Amsterdam
- Gelre Hospitals, Apeldoorn
- Leiden University Medical Center, Leiden
- Tergooi, Hilversum
- Vrije Universiteit University Medical Center, Amsterdam
- Westfries Gasthuis, Hoorn
Ethics Approval: The Institutional Review Board of the Academic Medical Center approved of the study on 15 May 2014
Monitoring:
- Monitoring of patients safety and reviewing of safety issues is performed by a designated independent Data Safety and Monitoring Board (DSMB).The DSMB watches over the ethics of conducting the study in accordance with the Declaration of Helsinki. This study compares two treatment strategies that are used in standard care, therefore no related serious adverse events (SAEs) are expected. All unexpected and related or possibly related adverse events will be reported to the DSMB
- An independent monitor will perform clinical trial monitoring. On-site monitoring will comprise controlling presence and completeness of the research dossier and the informed consent forms, source data checks will be performed. Every participating center will be visited at least once every year.
Study Population:
Adult ICU-patients without ARDS with an expected duration of ventilation longer than 24 hours, within 1 hour after initiation of ventilation or admittance to the ICU if already intubated and ventilated on admission.
Sample Size Calculation:
The required sample size is calculated using data from the recently published meta-analysis and a secondary analysis of this meta-analysis using individual patient data from the studies performed in ICU patients [submitted for publication]. The sample size is computed on the basis of the hypothesis that ventilation with lower tidal volumes is associated with a reduction of one day of ventilation. A sample size of 397 patients in each group has 80% statistical power to detect a difference of one ventilator-free day and alive at day 28 after ICU admission, with means of 23 and 24 days respectively. Assuming that the common standard deviation is 5 using a two group t-test with a 0.05 two-sided significance level. The sample size is increased by 20% to correct for dropouts and lost to follow up (i.e., because patients could be transferred to other hospitals), meaning that each group will contain 476 patients.
Methods:
Patients in participating intensive care units (ICU) are screened and randomized within 1 hour of start of mechanical ventilation in the unit. Demographic data on screened patients regardless of meeting enrollment criteria will be recorded (registry: age, gender, type of surgery). Randomization will be performed using a dedicated, password protected, SSL-encrypted website. Randomization sequence is generated by a dedicated computer randomization software program using random block sizes and is stratified per center and per intubation location (i.e., in the ICU or before ICU admittance in the operation room or in the emergency room). No blocking is applied to other trial factors. Due to the nature of the intervention, blinding is not possible.
Patients are randomly assigned in a 1:1 ratio to lower tidal volume ventilation (4 to 6 ml/kg PBW) (the 'lower tidal volume'-arm) or ventilation with higher tidal volumes (8 to 10 ml/kg PBW) (the 'higher tidal volume'-arm).
The allowed ventilation modes are volume controlled ventilation and pressure support ventilation. The inspiration-to-expiration ratio with volume controlled ventilation is 1:2. With volume controlled ventilation the inspiration time and pause are set at 25% and 10% respectively. With pressure support ventilation the highest possible pressure rise is chosen, and cycling off is set at 25%. The inspired oxygen fraction is 0.21 or higher to maintain oxygen saturation 90 to 92% and/or PaO2 > 7.3 to 10.7 kPa (55 to 80 mmHg). The respiratory rate is adjusted to maintain a blood pH of 7.25 to 7.45. In case of metabolic acidosis or - alkalosis, a lower or higher than normal PaCO2 can be accepted, left to the discretion of the attending physician. The lowest level of positive end-expiratory pressure is 5 cmH2O. Recruitment maneuvers are allowed, when deemed necessary, left to the discretion of the attending physician. In both arms a tidal volume is titrated per PBW, which is calculated according to a previously used formula: 50 + 0.91 x (centimeters of height - 152.4) for males and 45.5 + 0.91 x (centimeters of height - 152.4) for females.
- Patients randomized to the 'lower tidal volume'-arm start with a tidal volume of 6 ml/kg PBW. The tidal volume size is decreased in steps of 1 ml/kg PBW per hour, to a minimum of 4 ml/kg PBW, unless the patient suffers from severe dyspnea (identified by increased respiratory rate > 35 breaths per minute accompanied by increasing levels of discomfort with or without need for more sedation) or unacceptable acidosis.The following measures can be taken to prevent respiratory acidosis: increasing respiratory rate and decreasing instrumental dead space by shortening ventilation tubing, to limit dead space ventilation. Patients randomized to the lower tidal volume arm may need very little support when the ventilator is switched to pressure support ventilation, but a minimum of 5 cmH2O should be used. In case the resulting tidal volume exceeds 6 ml/kg PBW this must be accepted
- Patients randomized to the 'higher tidal volume'-arm start with a tidal volume of 10 ml/kg PBW. With volume-controlled ventilation the plateau pressure should not exceed 25 cm H2O. Only if the plateau pressure exceeds 25 cm H2O the tidal volume is decreased in steps of 1 ml/kg PBW per hour, to a minimum of 8 ml/kg PBW (table 1). With pressure support, tidal volume titration is by variation of the pressure support level. Other modes of ventilation are not allowed.Patients randomized to the higher tidal volume arm generally need more support when the ventilator is switched to pressure support ventilation, but the maximal airway pressure should not exceed 25 cm H2O [2]. In case the resulting tidal volume remains below 10 ml/kg PBW this must be accepted.
- Daily assessment of the ability to breathe with pressure support ventilation is required as soon as FiO2 ≤ 0.4 or when the PEEP level and FiO2 level are lower than the day before. Other modes of ventilation are not allowed.In addition, the ventilator can be switched to pressure support ventilation at any moment the attending nurse or physician consider the patient is awake enough to breathe with pressure support ventilation. Assessment of the ability to breathe with pressure support is also required in case patient-ventilator asynchrony is noticed (ineffective breathing; double triggering, use of assessory respiratory muscles). A patient is assumed to be ready for extubation when the following criteria are met for at least 30 minutes, the final decision for extubation is made by the attending physician:
- Responsive and cooperative
- Adequate cough reflex
- PaO2/FiO2 of > 200 mmHg with FiO2 ≤ 40%
- Respiratory rate of 8 to 30/minute
- No signs of respiratory distress (i.e., marked accessory muscle use, abdominal paradox, diaphoresis, marked dyspnea)
- Pressure support level < 7 cm H2O (lower tidal volume arm) or < 12 cm H2O (higher tidal volume arm)
- Hemodynamically stable (systolic blood pressure 80 to 160 mmHg and heart rate 40 to 130/min) and no uncontrolled arrhythmia
- Temperature > 36.0oC and < 38.5oC In the higher tidal volume arm physicians and nurses may decide to lower the pressure support level first (i.e., before extubation). For this, the pressure support level is lowered step-wise with steps of 2 to 5 cm H2O per hour to < 7 cm H2O. If this is not tolerated according to the conditions mentioned above, the pressure support level is set back to maintain a tidal volume as per randomization and the patient is assessed for extubation the following day. If a patient becomes able to breathe without assistance but subsequently requires additional ventilation within 28 days after randomization, the same tidal volume protocol is resumed. Non-invasive ventilation is allowed, but it should be tried to have comparable tidal volumes as with invasive ventilation, as per randomization.
Sedation follows the local guidelines for sedation in each participating units. In general, these guidelines favor the use of analgo-sedation over hypno-sedation, use of bolus over continuous infusion of sedating agents, and the use of sedation scores. Nurses determine the level of sedation at least 3 times per day. The adequacy of sedation in each patient is evaluated using a Richmond Agitation Sedation Scale (RASS). A RASS score of -2 to 0 is seen as adequate sedation. As stated above, sedation adjustments should never be done to allow a lower or higher tidal volume. The goals of sedation are to reduce agitation, stress and fear; to reduce oxygen consumption (heart rate, blood pressure and minute volume are measured continuously); and to reduce physical resistance to- and fear of daily care and medical examination. Patient comfort is the primary goal.
Statistical Analysis:
- The primary outcome, the number of ventilator-free days at day 28 after ICU admission, is analyzed using Cox's regression. Possible imbalance between groups will be modeled in the Cox model. P-values of 0.05 are used for statistical significance. When appropriate, statistical uncertainty will be expressed by the 95% confidence levels.
- Continuous normally distributed variables will be expressed by their mean and standard deviation or when not normally distributed as medians and their interquartile ranges. Categorical variables will be expressed as n (%). To test groups Student's t test will be used, if continuous data is not normally distributed the Mann-Whitney U test will be used. Categorical variables will be compared with the Chi-square test or Fisher's exact tests. Time dependent data will be analyzed using a proportional hazard model adjusted for possible imbalances of patients' baseline characteristics. Patient characteristics will be compared and described by appropriate statistics.
- The goal of the primary analysis is to quantify the effect of lower tidal volumes vs. higher tidal volumes on the number of ventilator free days and alive at day 28. Statistical analysis will be based on the intention-to-treat principle. We will also perform a per-protocol analysis, comparing patients who received lower tidal volumes and patients who received higher tidal volumes. Other secondary analyses include analysis of patients who had pneumonia versus patients without pneumonia, patients who fulfilled the definition for mild ARDS versus patients who did not fulfill this definition, and patients with sepsis versus patients without sepsis.
- Conditions
- Ventilator-free Days
- Being tested
- low tidal volume, high tidal volume
- Keywords
- low tidal volume, high tidal volume, protective ventilation, ARDS
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
low tidal volumeProcedure or surgery
Patients are randomized and ventilated with a low tidal volume (4-6 ml/kg PBW)
high tidal volumeProcedure or surgery
Patients are randomized and ventilated with a high tidal volume (8-10 ml/kg PBW)
| Study group | Role | What they receive |
|---|---|---|
| Ventilation with lower tidal volumes | Experimental | Use of low tidal volume (4 to 6 ml/kg PBW) after intubation and during all mechanical ventilation Receives: Procedure: low tidal volume |
| Ventilation with higher tidal volumes | Other | Use of high tidal volume (8 to 10 ml/kg PBW) after intubation and during all mechanical ventilation Receives: Procedure: high tidal volume |
What is being measured
The primary outcome is the main question the study is designed to answer.
Ventilator-free days
The number of ventilator-free days, defined as the number of days from day 1 to day 28 on which a patient breathes without assistance, if the period of unassisted breathing lasted at least 24 consecutive hours.
Measured: first 28 days after start of ventilation
Secondary outcomes (7)
Intensive care unit length of stay
Measured: first 90 days after start of ventilation
Hospital length of stay
Measured: first 90 days after start of ventilation
Cumulative use and duration of sedatives and neuromuscular blocking agents
Measured: first 28 days after start of ventilation or discharge from intensive care
ICU delirium
Development of delirium according to the Confusion Assessment Method for intensive care unit (CAM-ICU)
Measured: first 28 days after start of ventilation or discharge from intensive care
ICU- Acquired Weakness
Development of ICU-acquired weakness using the Medical Research Council (MRC) score and grip strength assessment
Measured: first 28 days after start of ventilation or discharge from intensive care
Mortality
Any death during ICU-, or hospital-stay and within 90 days
Measured: first 90 days after start of ventilation
Pulmonary complications
Development of ARDS according to the Berlin definition, pulmonary infection, atelectases and pneumothorax
Measured: first 28 days after start of ventilation or discharge from intensive care
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jun 2014 (estimated)
- Study startAug 2014
- Primary completion20 Sep 2017
- Study completion18 Nov 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Ventilator-free DaysStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 952 participants (actual)
Sponsor and investigators
- Lead sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Sponsor type
- University, hospital or other
- Collaborators
- Tergooi Hospital, Leiden University Medical Center, Gelre Hospitals, Amsterdam UMC, location VUmc, Westfries Hospital
- Responsible party
- Principal investigator, Prof. Dr. Marcus J. Schultz, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Investigators
- Marcus J Schultz, MD, PhD, Principal investigator, Department of Intensive Care, Academic Medical Center, University of AmsterdamFabienne D Simonis, MD, Study director, Academic Medical Center, University of Amsterdam, The NetherlandsMarcelo Gama de Abreu, MD, PhD, Study chair, Department of Anesthesiology and Intensive Care Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, GermanyPaolo Pelosi, MD, PhD, Study chair, Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, ItalyAry Serpa Neto, MD, MSc, Study chair, Department of Intensive Care, Academic Medical Center, University of Amsterdam, The NetherlandsJanneke Horn, MD, PhD, Principal investigator, Department of Intensive Care, Academic Medical Center, University of Amsterdam, The NetherlandsNicole P Juffermans, MD, PhD, Principal investigator, Department of Intensive Care, Academic Medical Center, University of Amsterdam, The NetherlandsJan M Binnekade, PhD, Principal investigator, Department of Intensive Care, Academic Medical Center, University of Amsterdam, The Netherlands
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02153294
- Sponsor's protocol ID
- PReVENT-NL
- Other IDs
- 80-83700-98-42001
- Acronym
- PReVENT-NL
- Status last verified
- Mar 2018
- First submitted
- 23 May 2014
- Last updated
- 26 Mar 2018
- Results posted
- No
- Data monitoring committee
- Yes
Publications
van Meenen DMP, Algera AG, Schuijt MTU, Simonis FD, van der Hoeven SM, Neto AS, Abreu MG, Pelosi P, Paulus F, Schultz MJ; for the NEBULAE; PReVENT; RELAx investigators. Effect of mechanical power on mortality in invasively ventilated ICU patients without the acute respiratory distress syndrome: An analysis of three randomised clinical trials. Eur J Anaesthesiol. 2023 Jan 1;40(1):21-28. doi: 10.1097/EJA.0000000000001778. Epub 2022 Nov 18.
PubMed 36398740Writing Group for the PReVENT Investigators; Simonis FD, Serpa Neto A, Binnekade JM, Braber A, Bruin KCM, Determann RM, Goekoop GJ, Heidt J, Horn J, Innemee G, de Jonge E, Juffermans NP, Spronk PE, Steuten LM, Tuinman PR, de Wilde RBP, Vriends M, Gama de Abreu M, Pelosi P, Schultz MJ. Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS: A Randomized Clinical Trial. JAMA. 2018 Nov 13;320(18):1872-1880. doi: 10.1001/jama.2018.14280.
PubMed 30357256Simonis FD, Binnekade JM, Braber A, Gelissen HP, Heidt J, Horn J, Innemee G, de Jonge E, Juffermans NP, Spronk PE, Steuten LM, Tuinman PR, Vriends M, de Vreede G, de Wilde RB, Serpa Neto A, Gama de Abreu M, Pelosi P, Schultz MJ. PReVENT--protective ventilation in patients without ARDS at start of ventilation: study protocol for a randomized controlled trial. Trials. 2015 May 24;16:226. doi: 10.1186/s13063-015-0759-1.
PubMed 26003545
Study at a glance
From the registry record, last updated by the sponsor on 26 Mar 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- PRotective VENTilation in Patients Without ARDS at Start of Ventilation - PReVENT, a Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT02153294
- Acronym / sponsor ID
- PReVENT-NL / PReVENT-NL
- Conditions
- Ventilator-free Days
- Keywords
- low tidal volume, high tidal volume, protective ventilation, ARDS
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 952 participants (actual)
- Lead sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)University, hospital or other
- Collaborators
- Tergooi Hospital, Leiden University Medical Center, Gelre Hospitals, Amsterdam UMC, location VUmc, Westfries Hospital
- Study start
- Aug 2014
- Primary completion
- 20 Sep 2017 (actual)
- Study completion
- 18 Nov 2017 (actual)
- First posted
- 3 Jun 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this national multicentre randomized controlled trial is to compare a ventilation strategy using lower tidal volumes and higher respiratory rates with a ventilation strategy using higher tidal volumes and a lower respiratory rate in intubated and ventilated intensive care unit (ICU) patients without Acute Respiratory Distress Syndrome (ARDS) at start of ventilation.
Participating centres in The Netherlands will include a total of 952 adult patients admitted to intensive care units without ARDS. Patients are randomized and ventilated with either a strategy with lower tidal volumes (4 to 6 ml/kg predicted body weight (PBW)) or a strategy with higher tidal volumes (8 to 10 ml/kg PBW). Patients will be assessed every day until day 28 or discharge of the intensive care unit, whichever comes first, on day 28 and on day 90. Primary endpoint is the number of ventilator-free days at day 28. Secondary endpoints are ICU- and hospital length of stay (LOS) and - mortality, the incidence of development of ARDS, pneumonia, atelectasis, and pneumothorax, the cumulative use and duration of sedatives, and neuromuscular blocking agents, incidences of ICU delirium and ICU acquired weakness, patient-ventilator asynchrony and the need for decreasing of instrumental dead space.
Detailed description
Research question:
Does mechanical ventilation with lower tidal volumes, as compared with mechanical ventilation with higher tidal volumes, increase the number of ventilator-free days at day 28 in patients without ARDS at start of ventilation?
Study Design:
An investigator-initiated, national, multicenter, parallel randomized controlled two-arm trial.
Centers:
Five centers in The Netherlands will participate in this trial;
- Academic Medical Center, University of Amsterdam
- Gelre Hospitals, Apeldoorn
- Leiden University Medical Center, Leiden
- Tergooi, Hilversum
- Vrije Universiteit University Medical Center, Amsterdam
- Westfries Gasthuis, Hoorn
Ethics Approval: The Institutional Review Board of the Academic Medical Center approved of the study on 15 May 2014
Monitoring:
- Monitoring of patients safety and reviewing of safety issues is performed by a designated independent Data Safety and Monitoring Board (DSMB).The DSMB watches over the ethics of conducting the study in accordance with the Declaration of Helsinki. This study compares two treatment strategies that are used in standard care, therefore no related serious adverse events (SAEs) are expected. All unexpected and related or possibly related adverse events will be reported to the DSMB
- An independent monitor will perform clinical trial monitoring. On-site monitoring will comprise controlling presence and completeness of the research dossier and the informed consent forms, source data checks will be performed. Every participating center will be visited at least once every year.
Study Population:
Adult ICU-patients without ARDS with an expected duration of ventilation longer than 24 hours, within 1 hour after initiation of ventilation or admittance to the ICU if already intubated and ventilated on admission.
Sample Size Calculation:
The required sample size is calculated using data from the recently published meta-analysis and a secondary analysis of this meta-analysis using individual patient data from the studies performed in ICU patients [submitted for publication]. The sample size is computed on the basis of the hypothesis that ventilation with lower tidal volumes is associated with a reduction of one day of ventilation. A sample size of 397 patients in each group has 80% statistical power to detect a difference of one ventilator-free day and alive at day 28 after ICU admission, with means of 23 and 24 days respectively. Assuming that the common standard deviation is 5 using a two group t-test with a 0.05 two-sided significance level. The sample size is increased by 20% to correct for dropouts and lost to follow up (i.e., because patients could be transferred to other hospitals), meaning that each group will contain 476 patients.
Methods:
Patients in participating intensive care units (ICU) are screened and randomized within 1 hour of start of mechanical ventilation in the unit. Demographic data on screened patients regardless of meeting enrollment criteria will be recorded (registry: age, gender, type of surgery). Randomization will be performed using a dedicated, password protected, SSL-encrypted website. Randomization sequence is generated by a dedicated computer randomization software program using random block sizes and is stratified per center and per intubation location (i.e., in the ICU or before ICU admittance in the operation room or in the emergency room). No blocking is applied to other trial factors. Due to the nature of the intervention, blinding is not possible.
Patients are randomly assigned in a 1:1 ratio to lower tidal volume ventilation (4 to 6 ml/kg PBW) (the 'lower tidal volume'-arm) or ventilation with higher tidal volumes (8 to 10 ml/kg PBW) (the 'higher tidal volume'-arm).
The allowed ventilation modes are volume controlled ventilation and pressure support ventilation. The inspiration-to-expiration ratio with volume controlled ventilation is 1:2. With volume controlled ventilation the inspiration time and pause are set at 25% and 10% respectively. With pressure support ventilation the highest possible pressure rise is chosen, and cycling off is set at 25%. The inspired oxygen fraction is 0.21 or higher to maintain oxygen saturation 90 to 92% and/or PaO2 > 7.3 to 10.7 kPa (55 to 80 mmHg). The respiratory rate is adjusted to maintain a blood pH of 7.25 to 7.45. In case of metabolic acidosis or - alkalosis, a lower or higher than normal PaCO2 can be accepted, left to the discretion of the attending physician. The lowest level of positive end-expiratory pressure is 5 cmH2O. Recruitment maneuvers are allowed, when deemed necessary, left to the discretion of the attending physician. In both arms a tidal volume is titrated per PBW, which is calculated according to a previously used formula: 50 + 0.91 x (centimeters of height - 152.4) for males and 45.5 + 0.91 x (centimeters of height - 152.4) for females.
- Patients randomized to the 'lower tidal volume'-arm start with a tidal volume of 6 ml/kg PBW. The tidal volume size is decreased in steps of 1 ml/kg PBW per hour, to a minimum of 4 ml/kg PBW, unless the patient suffers from severe dyspnea (identified by increased respiratory rate > 35 breaths per minute accompanied by increasing levels of discomfort with or without need for more sedation) or unacceptable acidosis.The following measures can be taken to prevent respiratory acidosis: increasing respiratory rate and decreasing instrumental dead space by shortening ventilation tubing, to limit dead space ventilation. Patients randomized to the lower tidal volume arm may need very little support when the ventilator is switched to pressure support ventilation, but a minimum of 5 cmH2O should be used. In case the resulting tidal volume exceeds 6 ml/kg PBW this must be accepted
- Patients randomized to the 'higher tidal volume'-arm start with a tidal volume of 10 ml/kg PBW. With volume-controlled ventilation the plateau pressure should not exceed 25 cm H2O. Only if the plateau pressure exceeds 25 cm H2O the tidal volume is decreased in steps of 1 ml/kg PBW per hour, to a minimum of 8 ml/kg PBW (table 1). With pressure support, tidal volume titration is by variation of the pressure support level. Other modes of ventilation are not allowed.Patients randomized to the higher tidal volume arm generally need more support when the ventilator is switched to pressure support ventilation, but the maximal airway pressure should not exceed 25 cm H2O [2]. In case the resulting tidal volume remains below 10 ml/kg PBW this must be accepted.
- Daily assessment of the ability to breathe with pressure support ventilation is required as soon as FiO2 ≤ 0.4 or when the PEEP level and FiO2 level are lower than the day before. Other modes of ventilation are not allowed.In addition, the ventilator can be switched to pressure support ventilation at any moment the attending nurse or physician consider the patient is awake enough to breathe with pressure support ventilation. Assessment of the ability to breathe with pressure support is also required in case patient-ventilator asynchrony is noticed (ineffective breathing; double triggering, use of assessory respiratory muscles). A patient is assumed to be ready for extubation when the following criteria are met for at least 30 minutes, the final decision for extubation is made by the attending physician:
- Responsive and cooperative
- Adequate cough reflex
- PaO2/FiO2 of > 200 mmHg with FiO2 ≤ 40%
- Respiratory rate of 8 to 30/minute
- No signs of respiratory distress (i.e., marked accessory muscle use, abdominal paradox, diaphoresis, marked dyspnea)
- Pressure support level < 7 cm H2O (lower tidal volume arm) or < 12 cm H2O (higher tidal volume arm)
- Hemodynamically stable (systolic blood pressure 80 to 160 mmHg and heart rate 40 to 130/min) and no uncontrolled arrhythmia
- Temperature > 36.0oC and < 38.5oC In the higher tidal volume arm physicians and nurses may decide to lower the pressure support level first (i.e., before extubation). For this, the pressure support level is lowered step-wise with steps of 2 to 5 cm H2O per hour to < 7 cm H2O. If this is not tolerated according to the conditions mentioned above, the pressure support level is set back to maintain a tidal volume as per randomization and the patient is assessed for extubation the following day. If a patient becomes able to breathe without assistance but subsequently requires additional ventilation within 28 days after randomization, the same tidal volume protocol is resumed. Non-invasive ventilation is allowed, but it should be tried to have comparable tidal volumes as with invasive ventilation, as per randomization.
Sedation follows the local guidelines for sedation in each participating units. In general, these guidelines favor the use of analgo-sedation over hypno-sedation, use of bolus over continuous infusion of sedating agents, and the use of sedation scores. Nurses determine the level of sedation at least 3 times per day. The adequacy of sedation in each patient is evaluated using a Richmond Agitation Sedation Scale (RASS). A RASS score of -2 to 0 is seen as adequate sedation. As stated above, sedation adjustments should never be done to allow a lower or higher tidal volume. The goals of sedation are to reduce agitation, stress and fear; to reduce oxygen consumption (heart rate, blood pressure and minute volume are measured continuously); and to reduce physical resistance to- and fear of daily care and medical examination. Patient comfort is the primary goal.
Statistical Analysis:
- The primary outcome, the number of ventilator-free days at day 28 after ICU admission, is analyzed using Cox's regression. Possible imbalance between groups will be modeled in the Cox model. P-values of 0.05 are used for statistical significance. When appropriate, statistical uncertainty will be expressed by the 95% confidence levels.
- Continuous normally distributed variables will be expressed by their mean and standard deviation or when not normally distributed as medians and their interquartile ranges. Categorical variables will be expressed as n (%). To test groups Student's t test will be used, if continuous data is not normally distributed the Mann-Whitney U test will be used. Categorical variables will be compared with the Chi-square test or Fisher's exact tests. Time dependent data will be analyzed using a proportional hazard model adjusted for possible imbalances of patients' baseline characteristics. Patient characteristics will be compared and described by appropriate statistics.
- The goal of the primary analysis is to quantify the effect of lower tidal volumes vs. higher tidal volumes on the number of ventilator free days and alive at day 28. Statistical analysis will be based on the intention-to-treat principle. We will also perform a per-protocol analysis, comparing patients who received lower tidal volumes and patients who received higher tidal volumes. Other secondary analyses include analysis of patients who had pneumonia versus patients without pneumonia, patients who fulfilled the definition for mild ARDS versus patients who did not fulfill this definition, and patients with sepsis versus patients without sepsis.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Ventilation with lower tidal volumes | Experimental | Procedure: low tidal volumeUse of low tidal volume (4 to 6 ml/kg PBW) after intubation and during all mechanical ventilation |
| Ventilation with higher tidal volumes | Other | Procedure: high tidal volumeUse of high tidal volume (8 to 10 ml/kg PBW) after intubation and during all mechanical ventilation |
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Admission to an ICU participating in this trial
- Need for intubation
- Within 1 hour of admission from the operation room or emergency room (if still intubated and ventilated), or within 1 hour of start of invasive ventilation in the ICU
- An expected duration of ventilation > 24 hours
Key exclusion criteria (13 listed)
- Age less than 18 years
- Patients previously randomized in PReVENT
- Patients participating in other interventional trials
- Patients with a clinical diagnosis of ARDS according to the Berlin definition
- Patients with a PaO2/FiO2 < 200 mm Hg in whom hypoxia is presumably not caused by cardiac failure or fluid overload
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| low tidal volumePatients are randomized and ventilated with a low tidal volume (4-6 ml/kg PBW) | Procedure or surgery | Ventilation with lower tidal volumes |
| high tidal volumePatients are randomized and ventilated with a high tidal volume (8-10 ml/kg PBW) | Procedure or surgery | Ventilation with higher tidal volumes |
Primary outcome
Ventilator-free days
Time frame: first 28 days after start of ventilation
The number of ventilator-free days, defined as the number of days from day 1 to day 28 on which a patient breathes without assistance, if the period of unassisted breathing lasted at least 24 consecutive hours.
7 secondary outcomes
Intensive care unit length of stay
Time frame: first 90 days after start of ventilation
Hospital length of stay
Time frame: first 90 days after start of ventilation
Cumulative use and duration of sedatives and neuromuscular blocking agents
Time frame: first 28 days after start of ventilation or discharge from intensive care
ICU delirium
Time frame: first 28 days after start of ventilation or discharge from intensive care
ICU- Acquired Weakness
Time frame: first 28 days after start of ventilation or discharge from intensive care
Mortality
Time frame: first 90 days after start of ventilation
Pulmonary complications
Time frame: first 28 days after start of ventilation or discharge from intensive care
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Mar 2018.
- Derived from this study: PubMed 36398740van Meenen DMP, Algera AG, Schuijt MTU, Simonis FD, van der Hoeven SM, Neto AS, Abreu MG, Pelosi P, Paulus F, Schultz MJ; for the NEBULAE; PReVENT; RELAx investigators. Effect of mechanical power on mortality in invasively ventilated ICU patients without the acute respiratory distress syndrome: An analysis of three randomised clinical trials. Eur J Anaesthesiol. 2023 Jan 1;40(1):21-28. doi: 10.1097/EJA.0000000000001778. Epub 2022 Nov 18.
- Derived from this study: PubMed 30357256Writing Group for the PReVENT Investigators; Simonis FD, Serpa Neto A, Binnekade JM, Braber A, Bruin KCM, Determann RM, Goekoop GJ, Heidt J, Horn J, Innemee G, de Jonge E, Juffermans NP, Spronk PE, Steuten LM, Tuinman PR, de Wilde RBP, Vriends M, Gama de Abreu M, Pelosi P, Schultz MJ. Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS: A Randomized Clinical Trial. JAMA. 2018 Nov 13;320(18):1872-1880. doi: 10.1001/jama.2018.14280.
- Derived from this study: PubMed 26003545Simonis FD, Binnekade JM, Braber A, Gelissen HP, Heidt J, Horn J, Innemee G, de Jonge E, Juffermans NP, Spronk PE, Steuten LM, Tuinman PR, Vriends M, de Vreede G, de Wilde RB, Serpa Neto A, Gama de Abreu M, Pelosi P, Schultz MJ. PReVENT--protective ventilation in patients without ARDS at start of ventilation: study protocol for a randomized controlled trial. Trials. 2015 May 24;16:226. doi: 10.1186/s13063-015-0759-1.
Related trials for Ventilator-free Days
Not yet recruitingObservational study
Intra-Abdominal Pressure, Respiratory Mechanics, and Ventilator Liberation After Emergency Major Laparotomy
Intra-Abdominal Hypertension, Respiratory Mechanics
Not yet recruitingObservational study
Effect of Albumin Therapy in Mechanically Ventilated Patients With Sepsis-Associated ARDS
Acute Respiratory Distress Syndrome, Sepsis
Recruiting
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Acute Hypoxic Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS)
RecruitingPhase 3
Clinical Trial With Aprotinin in the Acute Respiratory Distress Syndrome Treatment
Acute Respiratory Distress Syndrome (ARDS)
Recruiting
Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy
Mechanical Ventilation Complication
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Marcus J Schultz, MD, PhD principal investigator
Department of Intensive Care, Academic Medical Center, University of Amsterdam
Fabienne D Simonis, MD study director
Academic Medical Center, University of Amsterdam, The Netherlands
Marcelo Gama de Abreu, MD, PhD study chair
Department of Anesthesiology and Intensive Care Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Germany
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing low tidal volume and high tidal volume in people with Ventilator-free Days, run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) at 1 site in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Ventilator-free days (time frame: first 28 days after start of ventilation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02153294, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2018.